Symptomatic atherosclerotic disease and decreased risk of cancer-specific mortality: A prospective, population-based study (NEDICES)

Medicine (United States)

Volumn 94, Issue 32, 2015, Pages

  Benito León, Julián ^a,b,c   De La Aleja, Jesús González ^a,b   Martínez Salio, Antonio ^a   Louis, Elan D ^d,e   Lichtman, Judith H ^a,d,e   Bermejo Pareja, Félix ^c   Aykan, Ahmet ^f  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b SCHOOL OF MEDICINE   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e YALE UNIVERSITY   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ALCOHOLISM; ANGINA PECTORIS; ARTICLE; ATHEROSCLEROSIS; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; DEATH CERTIFICATE; DEMENTIA; DIGESTIVE SYSTEM CANCER; FEMALE; GENDER; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OVERALL SURVIVAL; PERITONEUM CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SECONDARY ANALYSIS; SMOKING; TRANSIENT ISCHEMIC ATTACK; WAIST CIRCUMFERENCE; HEALTH BEHAVIOR; HEALTH STATUS; MIDDLE AGED; MORTALITY; NEOPLASMS; RISK FACTOR; SPAIN; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; COMORBIDITY; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 84942379776     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001287     Document Type: Article

References (50)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer Journal international du cancer. 2015; 136: E359-E386.
2. Bennett DA, Krishnamurthi RV, Barker-Collo S, et al. The global burden of ischemic stroke: findings of the GBD 2010 Study. Glob Heart. 2014; 9: 107-112.
3. Brundtland GH From the World Health Organization. Reducing risks to health, promoting healthy life. JAMA. 2002; 288: 1974.
4. Hansen ES International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/2. Shared risk factors for cancer and atherosclerosis - a review of the epidemiological evidence. Mutat Res. 1990; 239: 163-179.
5. Vidal-Vanaclocha F. Inflammation in the molecular pathogenesis of cancer and atherosclerosis. Reumatol Clin. 2009; 5(SUPPL. 1): 40-43.
6. Bamias A, Dimopoulos MA. Inhibition of angiogenesis: common theme for cancer and atheromatosis? Hellenic J Cardiol. 2006; 47: 11-12.
7. Nilsson G, Holmberg L, Garmo H, et al. Increased incidence of stroke in women with breast cancer. Eur J Cancer. 2005; 41: 423-429.
8. Hooning MJ, Dorresteijn LD, Aleman BM, et al. Decreased risk of stroke among 10-year survivors of breast cancer. J Clin Oncol. 2006; 24: 5388-5394.
9. Zoller B, Ji J, Sundquist J, et al. Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012; 48: 1875-1883.
10. Zoller B, Ji J, Sundquist J, et al. Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012; 48: 121-128.
11. Navi BB, Reiner AS, Kamel H, et al. Association between incident cancer and subsequent stroke. Ann Neurol. 2014; 77: 291-300.
12. Dreyer L, Olsen JH. Cancer risk of patients discharged with acute myocardial infarct. Epidemiology. 1998; 9: 178-183.
13. Dreyer L, Olsen JH. Risk for non-smoking-related cancer in atherosclerotic patients. Cancer Epidemiol Biomarkers Prev. 1999; 8: 915-918.
14. Dreyer L, Prescott E, Gyntelberg F. Association between atherosclerosis and female lung cancer - a Danish cohort study. Lung Cancer. 2003; 42: 247-254.
15. Erichsen R, Svaerke C, Sorensen HT, et al. Risk of colorectal cancer in patients with acute myocardial infarction and stroke: a nationwide cohort study. Cancer Epidemiol Biomarkers Prev. 2013; 22: 1994-1999.
16. Bronnum-Hansen H, Davidsen M, Thorvaldsen P, et al. Long-term survival and causes of death after stroke. Stroke. 2001; 32: 2131-2136.
17. Romero JP, Benito-León J, Louis ED, et al. Alzheimer's disease is associated with decreased risk of cancer-specific mortality: a prospective study (NEDICES). J Alzheimers Dis. 2014; 40: 465-473.
18. Benito-León J, Romero JP, Louis ED, Bermejo-Pareja F. Faster cognitive decline in elders without dementia and decreased risk of cancer mortality: NEDICES Study. Neurology. 2014; 82: 1441-1448.
19. Catalá-López F, Suárez-Pinilla M, Suárez-Pinilla P, et al. Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom. 2014; 83: 89-105.
20. Morales JM, Bermejo FP, Benito-León J, et al. Methods and demographic findings of the baseline survey of the NEDICES cohort: a door-to-door survey of neurological disorders in three communities from Central Spain. Public Health. 2004; 118: 426-433.
21. Bermejo-Pareja F, Benito-León J, Vega QS, et al. The NEDICES cohort of the elderly. Methodology and main neurological findings. Rev Neurol. 2008; 46: 416-423.
22. Vega S, Benito-León J, Bermejo-Pareja F, et al. Several factors influenced attrition in a population-based elderly cohort: neurological disorders in Central Spain Study. J Clin Epidemiol. 2010; 63: 215-222.
23. Díaz-Guzmán J, Bermejo-Pareja F, Benito-León J, et al. Prevalence of stroke and transient ischemic attack in three elderly populations of central Spain. Neuroepidemiology. 2008; 30: 247-253.
24. Martínez-Salio A, Benito-León J, Díaz-Guzmán J, et al. Cerebrovascular disease incidence in central Spain (NEDICES): a population-based prospective study. J Neurol Sci. 2010; 298: 85-90.
25. Bermejo-Pareja F, Benito-León J, Vega S, et al. Consistency of clinical diagnosis of dementia in NEDICES: a population-based longitudinal study in Spain. J Geriatr Psychiatry Neurol. 2009; 22: 246-255.
26. Bermejo-Pareja F, Benito-León J, Vega S, Medrano MJ, Román GC. Incidence and subtypes of dementia in three elderly populations of central Spain. J Neurol Sci. 2008; 264: 63-72.
27. Benito-León J, Bermejo-Pareja F, Rodríguez J, et al. Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord. 2003; 18: 267-274.
28. Benito-León J, Bermejo-Pareja F, Morales-González JM, et al. Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology. 2004; 62: 734-741.
29. Posada IJ, Benito-León J, Louis ED, et al. Mortality from Parkinson's disease: a population-based prospective study (NEDICES). Mov Disord. 2011; 26: 2522-2529.
30. Benito-León J, Bermejo-Pareja F, Morales JM, et al. Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord. 2003; 18: 389-394.
31. Benito-León J, Bermejo-Pareja F, Louis ED. Neurological Disorders in Central Spain Study G. Incidence of essential tremor in three elderly populations of central Spain. Neurology. 2005; 64: 1721-1725.
32. Louis ED, Benito-León J, Ottman R, et al., Neurological Disorders in Central Spain Study G. A population-based study of mortality in essential tremor. Neurology. 2007; 69: 1982-1989.
33. Benito-León J, Louis ED, Villarejo-Galende A, et al. Long sleep duration in elders without dementia increases risk of dementia mortality (NEDICES). Neurology. 2014; 83: 1530-1537.
34. Carey IM, Shah SM, Harris T, et al. A new simple primary care morbidity score predicted mortality and better explains between practice variations than the Charlson index. J Clin Epidemiol. 2013; 66: 436-444.
35. Benito-León J, Louis ED, Bermejo-Pareja F. Cognitive decline in short and long sleepers: a prospective population-based study (NEDICES). J Psychiatr Res. 2013; 47: 1998-2003.
36. Benito-León J, Mitchell AJ, Hernández-Gallego J, et al. Obesity and impaired cognitive functioning in the elderly: a population-based cross-sectional study (NEDICES). Eur J Neurol. 2013; 20: 899-906 e876-e877.
37. Xu WH Large artery: an important target for cerebral small vessel diseases. Ann Transl Med. 2014; 2: 78.
38. Gabriel R, Alonso M, Reviriego B, et al. Ten-year fatal and nonfatal myocardial infarction incidence in elderly populations in Spain: the EPICARDIAN cohort study. BMC Public Health. 2009; 9: 360.
39. Budczies J, von Winterfeld M, Klauschen F, et al. Comprehensive analysis of clinico-pathological data reveals heterogeneous relations between atherosclerosis and cancer. J Clin Pathol. 2014; 67: 482-490.
40. Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009; 460: 587-591.
41. Yang Y, Duan W, Li Y, et al. New role of silent information regulator 1 in cerebral ischemia. Neurobiol Aging. 2013; 34: 2879-2888.
42. Gorenne I, Kumar S, Gray K, et al. Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis. Circulation. 2013; 127: 386-396.
43. Kumar R, Chaterjee P, Sharma PK, et al. Sirtuin1: a promising serum protein marker for early detection of Alzheimer's disease. PLoS One. 2013; 8: e61560.
44. Song NY, Surh YJ. Janus-faced role of SIRT1 in tumorigenesis. Ann N Y Acad Sci. 2012; 1271: 10-19.
45. Le PN, McDermott JD, Jimeno A. Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28. Pharmacol Ther. 2015; 146C: 1-11.
46. García-Martín A, Reyes-García R, García-Fontana B, et al. Relationship of Dickkopf1 (DKK1) with cardiovascular disease and bone metabolism in Caucasian type 2 diabetes mellitus. PloS One. 2014; 9: e111703.
47. Minamino T, Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res. 2007; 100: 15-26.
48. Holdt LM, Sass K, Gabel G, et al. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF) and MTAP in human atherosclerotic plaque. Atherosclerosis. 2011; 214: 264-270.
49. Rayess H, Wang MB, Srivatsan ES. Cellular senescence and tumor suppressor gene p16. Int J Cancer. 2012; 130: 1715-1725.
50. Pérez-Gomez B, Aragonés N, Pollán M, et al. Accuracy of cancer death certificates in Spain: a summary of available information. Gac Sanit. 2006; 20(SUPPL. 3): 42-51.